Sulzer Medica IntraCoil Peripheral Stent Approved Despite Panel Reservations
This article was originally published in The Gray Sheet
Executive Summary
Sulzer Medica's Intratherapeutics unit expects sales of the IntraCoil stent to double over the next year, following PMA approval April 8 for primary stenting of the femoral and popliteal arteries